FDA Approves Amyvid™ (Florbetapir F 18 Injection) for Use in Patients

By WebmasterApril 6, 2012November 1st, 2024No Comments

FDA Approves Amyvid™ (Florbetapir F 18 Injection) for Use in Patients
Read more here

Previous PostGalleon Pharmaceuticals Reports Positive Results from Phase I Study of GAL-021 For Treatment of Respiratory Depression
Next PostNiiki Pharma Presents Data on NKP-2235, the First Highly Orally Bioavailable Gallium-Based Anti-Cancer Agent